ZURICH-SCHLIEREN, Switzerland, Sept. 9, 2020 /PRNewswire/ -- TOPADUR Pharma AG, a clinical stage biopharmaceutical start-up company developing new dual-mode of action drugs that target the cGMP-enzyme regulation system, today announces that it has implemented CDD Vault. The company's...
from PR Newswire: https://ift.tt/33ag3St
No comments:
Post a Comment